Christina Kay

Insider Reports History

Reporting-owner location: Hillside, NJ
Latest reporting-owner signature: /s/ Christina Kay
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christina Kay

Form 4 holding Co-Chief Executive Officer, Director, 10%+ Owner

INTEGRATED BIOPHARMA INC

Security class: Common Stock
Shares / value: 1,473,467
Estimated value: $132,612
Report date: 21 May 2025
Price: $0.0900
Ownership: Direct

Form 4 holding Co-Chief Executive Officer, Director, 10%+ Owner

INTEGRATED BIOPHARMA INC

Security class: Stock Option (Right to Buy)
Shares / value: 140,000
Estimated value
Report date: 09 Dec 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Christina Kay

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 09 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Dec 2025, 17:30
Role: Co-Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 21 May 2025
Transactions: 2
Transaction value: +$13,000
Accepted by SEC: 22 May 2025, 17:56
Role: Co-Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 04 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Dec 2024, 12:41
Role: Co-Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 25 Nov 2024
Transactions: 2
Transaction value: +$5,000
Accepted by SEC: 25 Nov 2024, 17:08
Role: Co-Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 28 Nov 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Nov 2023, 18:31
Role: Co-Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 30 May 2023
Transactions: 1
Transaction value: +$17,000
Accepted by SEC: 01 Jun 2023, 14:38
Role: Co-Chief Executive Officer, Director
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 25 May 2023
Transactions: 6
Transaction value: +$1,368,705
Accepted by SEC: 21 Sep 2023, 15:41
Role: Co-Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 09 Nov 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Nov 2022, 17:53
Role: Co-Chief Executive Officer, Director
Next action: Open filing details

4 INBP

INTEGRATED BIOPHARMA INC

Report period: 03 Nov 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Nov 2021, 18:25
Role: Co-Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .